Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shinpei Yamaba"'
Autor:
Shinpei Yamaba, Yukinori Imai, Kayoko Sugawara, Yoshihito Uchida, Akira Fuchigami, Hiroshi Uchiya, Nobuaki Nakayama, Satoshi Mochida
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0298770 (2024)
AimTo clarify the efficacy of atezolizumab (ATZ) plus bevacizumab (BEV) as the second-line therapy for patients with unresectable hepatocellular carcinoma (HCC).MethodsThe subjects were 82 patients with HCC receiving ATZ/BEV, including 33 patients wi
Externí odkaz:
https://doaj.org/article/8812e3f451694156a06fd5997bd55d92
Autor:
Yoshihito Uchida, Hayato Uemura, Daisuke Hamada, Satoshi Mochida, Norihito Tarumoto, Shigefumi Maesaki, Shinpei Yamaba
Publikováno v:
Journal of Gastroenterology
Background COVID-19 has emerged as a threat to human health. Liver dysfunction has been reported to occur frequently in patients with COVID-19, although its significance has not yet been elucidated. Methods The subjects were 35 patients with COVID-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2100230c175b7bd4e6f6137c4da60da
https://doi.org/10.1007/s00535-020-01717-4
https://doi.org/10.1007/s00535-020-01717-4
Autor:
Manabu Nakazawa, Yukinori Imai, Yoichi Saito, Masamitsu Nakao, Yohei Fujii, Hayato Uemura, Satoshi Mochida, Yoshihito Uchida, Mie Inao, Tomoaki Tomiya, Kayoko Sugawara, Keisuke Shiokawa, Kayoko Naiki, Daisuke Motoya, Shinpei Yamaba, Nobuaki Nakayama, Satsuki Ando, Jun-ichi Kouyama, Hiroshi Uchiya, Akira Fuchigami
Publikováno v:
Hepatology Research. 48:233-243
Aim To improve the therapeutic efficacy of sofosbuvir/ledipasvir (SOF/LDV) for the retreatment of patients after daclatasvir/asunaprevir (DCV/ASV), a customized therapy with or without lead-in interferon (IFN)-β injections was formulated according t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f814bced0f65a2b3e0b88c6a2c83afa
https://doi.org/10.1111/hepr.12980
https://doi.org/10.1111/hepr.12980
Autor:
Hayato, Uemura, Yoshihito, Uchida, Jun-Ichi, Kouyama, Kayoko, Naiki, Shinpei, Yamaba, Akira, Fuchigami, Yoichi, Saito, Keisuke, Shiokawa, Yohei, Fujii, Hiroshi, Uchiya, Manabu, Nakazawa, Satsuki, Ando, Masamitsu, Nakao, Daisuke, Motoya, Kayoko, Sugawara, Mie, Inao, Yukinori, Imai, Nobuaki, Nakayama, Tomoaki, Tomiya, Satoshi, Mochida
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 48(4)
To improve the therapeutic efficacy of sofosbuvir/ledipasvir (SOF/LDV) for the retreatment of patients after daclatasvir/asunaprevir (DCV/ASV), a customized therapy with or without lead-in interferon (IFN)-β injections was formulated according to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c944f47a26f35758e4e12d6cf09a2757
https://pubmed.ncbi.nlm.nih.gov/28884930
https://pubmed.ncbi.nlm.nih.gov/28884930